- Corporate Officers - R
- Rastetter William H
Insider Trading History of Rastetter William H
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rastetter William H since 2015.
This trader's CIK number is 1205903.
At the time of last reporting, Rastetter William H was the Director of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
Note that in the past
RASTETTER WILLIAM H also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fate Therapeutics Inc (FATE) by Rastetter William H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | FATE | 0 | $0 | 0 | $0 | 28,461 | $38,991 |
| 2016 | FATE | 375,939 | $999,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Illumina, Inc. (ILMN) by Rastetter William H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | ILMN | 0 | $0 | 16,000 | $3,049,056 | 16,000 | $99,600 |
Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Rastetter William H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | NBIX | 0 | $0 | 48,000 | $6,038,628 | 50,869 | $2,144,820 |
| 2024 | NBIX | 0 | $0 | 25,294 | $3,542,264 | 20,000 | $259,600 |
| 2023 | NBIX | 0 | $0 | 11,237 | $1,164,741 | 20,000 | $254,199 |
| 2022 | NBIX | 0 | $0 | 10,728 | $1,018,366 | 20,000 | $133,200 |
| 2018 | NBIX | 0 | $0 | 9,500 | $855,000 | 20,000 | $141,000 |
| 2017 | NBIX | 0 | $0 | 10,750 | $454,510 | 25,000 | $54,250 |
Yearly summary of insider trading at Regulus Therapeutics Inc. (RGLS) by Rastetter William H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | RGLS | 92,889 | $100,320 | 0 | $0 | 0 | $0 |
| 2017 | RGLS | 274,725 | $249,999 | 0 | $0 | 0 | $0 |
| 2015 | RGLS | 100,000 | $1,016,995 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Rastetter William H:
1. Fate Therapeutics Inc (FATE)
2. Illumina, Inc. (ILMN)
3. Neurocrine Biosciences Inc (NBIX)
4. Regulus Therapeutics Inc. (RGLS)
Table 1. Insider trading of Fate Therapeutics Inc (FATE) by Rastetter William H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-30 | FATE | Option Ex | 28,461 | 1.37 | 38,991 |
| 2016-11-23 | FATE | Buy | 375,939 | 2.66 | 999,997 |
Table 2. Insider trading of Illumina, Inc. (ILMN) by Rastetter William H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-01-20 | ILMN | Option Ex | 16,000 | 6.22 | 99,600 |
| 2015-01-20 | ILMN | Sale | 16,000 | 190.57 | 3,049,056 |
Table 3. Insider trading of Neurocrine Biosciences Inc (NBIX) by Rastetter William H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-11-05 | NBIX | Option Ex | 18,000 | 47.89 | 862,020 |
| 2025-11-05 | NBIX | Sale | 18,000 | 151.82 | 2,732,688 |
| 2025-05-22 | NBIX | Option Ex | 2,869 | .00 | 0 |
| 2025-05-05 | NBIX | Sale | 30,000 | 110.20 | 3,305,940 |
| 2025-05-05 | NBIX | Option Ex | 30,000 | 42.76 | 1,282,800 |
| 2024-08-15 | NBIX | Sale | 14,250 | 146.69 | 2,090,332 |
| 2024-01-02 | NBIX | Sale | 11,044 | 131.47 | 1,451,932 |
| 2024-01-02 | NBIX | Option Ex | 20,000 | 12.98 | 259,600 |
| 2023-05-01 | NBIX | Option Ex | 7,625 | 12.71 | 96,913 |
| 2023-05-01 | NBIX | Sale | 4,300 | 101.43 | 436,136 |
| 2023-04-19 | NBIX | Option Ex | 1,610 | 12.71 | 20,463 |
| 2023-04-21 | NBIX | Option Ex | 10,765 | 12.71 | 136,823 |
| 2023-04-19 | NBIX | Sale | 903 | 105.00 | 94,818 |
| 2023-04-21 | NBIX | Sale | 6,034 | 105.04 | 633,787 |
| 2022-04-01 | NBIX | Option Ex | 20,000 | 6.66 | 133,200 |
| 2022-04-01 | NBIX | Sale | 10,728 | 94.93 | 1,018,366 |
| 2018-01-24 | NBIX | Option Ex | 20,000 | 7.05 | 141,000 |
| 2018-01-24 | NBIX | Sale | 9,500 | 90.00 | 855,000 |
| 2017-02-01 | NBIX | Sale | 10,750 | 42.28 | 454,510 |
| 2017-02-01 | NBIX | Option Ex | 25,000 | 2.17 | 54,250 |
Table 4. Insider trading of Regulus Therapeutics Inc. (RGLS) by Rastetter William H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-07 | RGLS | Buy | 92,889 | 1.08 | 100,320 |
| 2017-07-25 | RGLS | Buy | 274,725 | .91 | 249,999 |
| 2015-07-20 | RGLS | Buy | 38,765 | 10.13 | 392,766 |
| 2015-07-21 | RGLS | Buy | 61,235 | 10.19 | 624,229 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Rastetter William H
(Director of Neurocrine Biosciences Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.